ERBB2 and small cell lung carcinoma: Trastuzumab recognized HER2 in six of 10 SCLC cell lines of Japanese origin but in none of three cell lines of Caucasian origin (Supplementary Figure 2a), suggesting the existence of ethnic difference about HER2 expression in SCLC.